JUBILANT RADIOPHARMA Trademark

Trademark Overview


On Wednesday, March 31, 2021, a trademark application was filed for JUBILANT RADIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the JUBILANT RADIOPHARMA trademark a serial number of 79318292. The federal status of this trademark filing is REGISTERED as of Tuesday, November 1, 2022. This trademark is owned by Jubilant Pharmova Limited. The JUBILANT RADIOPHARMA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Radiopharmaceutical compositions for diagnostic or therapeutic use, namely, diagnostic radiopharmaceutical preparations and radiopharmaceuticals for the treatment of cancer, cardiovascular disease, lung disease, thyroid disease, bone disease, brain disease, and bodily tissue disease

Medical apparatus used to administer, dose, and monitor radioisotopes infusion in patient, namely, infusion and injection devices for administering drugs and pharmaceuticals
jubilant radiopharma

General Information


Serial Number79318292
Word MarkJUBILANT RADIOPHARMA
Filing DateWednesday, March 31, 2021
Status700 - REGISTERED
Status DateTuesday, November 1, 2022
Registration Number6886543
Registration DateTuesday, November 1, 2022
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 16, 2022

Trademark Statements


Description of MarkThe mark consists of the stylized blue wording "JUBILANT RADIOPHARMA" outlined in black.
Goods and ServicesRadiopharmaceutical compositions for diagnostic or therapeutic use, namely, diagnostic radiopharmaceutical preparations and radiopharmaceuticals for the treatment of cancer, cardiovascular disease, lung disease, thyroid disease, bone disease, brain disease, and bodily tissue disease
Indication of Colors claimedThe color(s) blue and black is/are claimed as a feature of the mark.
Goods and ServicesMedical apparatus used to administer, dose, and monitor radioisotopes infusion in patient, namely, infusion and injection devices for administering drugs and pharmaceuticals
Disclaimer with Predetermined Text"RADIOPHARMA"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 20, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, August 20, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJubilant Pharmova Limited
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressIN

Party NameJubilant Pharmova Limited
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressIN

Party NameJubilant Pharmova Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressIN

Trademark Events


Event DateEvent Description
Tuesday, March 21, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, February 27, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, February 27, 2023FINAL DISPOSITION PROCESSED
Wednesday, February 1, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 1, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 1, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 16, 2022NOTIFICATION PROCESSED BY IB
Tuesday, August 16, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 16, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 27, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 27, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 27, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Thursday, July 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 14, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, July 14, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 14, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, July 14, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 13, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 13, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, January 30, 2022REFUSAL PROCESSED BY IB
Thursday, January 13, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 13, 2022REFUSAL PROCESSED BY MPU
Wednesday, December 22, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 21, 2021NON-FINAL ACTION WRITTEN
Wednesday, December 15, 2021NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Tuesday, November 16, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, November 15, 2021NON-FINAL ACTION WRITTEN
Monday, November 15, 2021ASSIGNED TO EXAMINER
Tuesday, August 24, 2021APPLICATION FILING RECEIPT MAILED
Friday, August 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 19, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB